HSD17B13 and metabolic dysfunction-associated steatotic liver disease: However, to date, the biological role and molecular mechanism of HSD17B13 in the regulation of hepatic lipid metabolism and the pathogenesis of NAFLD/NASH remain incompletely characterized and poorly understood.